• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分布容积是大鼠体内酸性药物清除率体外-体内外推性差的一个指标。

The volume of distribution is an indicator of poor in vitro-in vivo extrapolation of clearance for acidic drugs in the rat.

作者信息

Sohlenius-Sternbeck Anna-Karin, Fagerholm Urban, Bylund Johan

机构信息

DMPK, CNSP iMed, AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden.

出版信息

Xenobiotica. 2013 Aug;43(8):671-8. doi: 10.3109/00498254.2012.755578. Epub 2013 Jan 16.

DOI:10.3109/00498254.2012.755578
PMID:23323549
Abstract

Abstract 1. We applied the regression offset approach to predict rat in vivo intrinsic clearance (CLint) for 54 new chemical acid entities with high plasma protein binding values and low renal clearance (CL). The prediction success was correlated to volume of distribution (Vd), molecular weight (Mw) and CL. 2. A correlation between poor in vitro-in vivo extrapolation (IVIVE) and Vd values distinct from the Vd of albumin (0.1-0.2 L/kg) was revealed. For compounds with a Vd value above 0.5 L/kg, 0% of the predictions of in vivo CLint was within twofold of the observed value, compared to 69% for compounds with a Vd value below 0.5 L/kg. 3.  Compounds with a Mw below 450 g/mol demonstrated more accurate in vivo CLint predictions than compounds with a Mw above 450 g/mol, i.e. 63% compared to 21% within twofold. For compounds with in vivo CL below 30% of the liver blood flow (LBF), 53% of the predictions was within twofold of the observed value, compared to 0% for compounds with CL above 30% of the LBF. 4. We show that accurate IVIVE for acidic compounds with high plasma protein binding and low renal CL can be associated with a low Vd (i.e. around the Vd of albumin) and with a low in vivo CL, and that Mw is an important optimization parameter for pharmacokinetic. This study also further demonstrates the advantages of the application of the regression method for identifying cases when metabolic CL is not the single major elimination pathway.

摘要

摘要 1. 我们应用回归偏移方法预测了54种具有高血浆蛋白结合值和低肾清除率(CL)的新型化学酸性实体的大鼠体内固有清除率(CLint)。预测成功率与分布容积(Vd)、分子量(Mw)和CL相关。2. 揭示了体外-体内外推(IVIVE)不佳与不同于白蛋白Vd(0.1 - 0.2 L/kg)的Vd值之间的相关性。对于Vd值高于0.5 L/kg的化合物,体内CLint预测值在观测值两倍范围内的比例为0%,而Vd值低于0.5 L/kg的化合物这一比例为69%。3. 分子量低于450 g/mol的化合物在体内CLint预测方面比分子量高于450 g/mol的化合物更准确,即在两倍范围内分别为63%和21%。对于体内CL低于肝血流量(LBF)30%的化合物,53%的预测值在观测值两倍范围内,而CL高于LBF 30%的化合物这一比例为0%。4. 我们表明,对于具有高血浆蛋白结合和低肾CL的酸性化合物,准确的IVIVE可能与低Vd(即接近白蛋白的Vd)和低体内CL相关,并且Mw是药代动力学的一个重要优化参数。本研究还进一步证明了应用回归方法在确定代谢CL不是单一主要消除途径的情况下的优势。

相似文献

1
The volume of distribution is an indicator of poor in vitro-in vivo extrapolation of clearance for acidic drugs in the rat.分布容积是大鼠体内酸性药物清除率体外-体内外推性差的一个指标。
Xenobiotica. 2013 Aug;43(8):671-8. doi: 10.3109/00498254.2012.755578. Epub 2013 Jan 16.
2
Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.从肝细胞数据推断人体代谢清除率的体外-体内外推新范例。
J Pharm Sci. 2013 Sep;102(9):3239-51. doi: 10.1002/jps.23502. Epub 2013 Mar 12.
3
Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL) from Hepatocyte Intrinsic Clearance (CL).药物设计与潜在的小鼠体外-体内外推法(IVIVE)在预测肝细胞内在清除率(CL)的血浆清除率(CL)方面的成功。
Mol Pharm. 2023 Jul 3;20(7):3438-3459. doi: 10.1021/acs.molpharmaceut.2c01001. Epub 2023 May 26.
4
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.制药研究和制造商协会(PhRMA)与美国疾病控制与预防中心(CPCDC)关于人体药代动力学预测模型的倡议,第3部分:人体清除率预测方法的比较评估
J Pharm Sci. 2011 Oct;100(10):4090-110. doi: 10.1002/jps.22552. Epub 2011 May 3.
5
Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.血浆蛋白结合在药物清除率预测中的影响:已发表研究的数据库分析及对体外-体内外推的启示
Drug Metab Dispos. 2021 Mar;49(3):188-201. doi: 10.1124/dmd.120.000294. Epub 2020 Dec 18.
6
Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.通过在体外-体内外推方法中结合代谢、转运和通透性数据来预测总肝清除率:重点关注药物在肝脏中的表观未结合分数。
J Pharm Sci. 2013 Jul;102(7):2085-95. doi: 10.1002/jps.23562. Epub 2013 Apr 23.
7
Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes.回归偏移法在预测肝细胞体内固有清除率中的实际应用。
Xenobiotica. 2012 Sep;42(9):841-53. doi: 10.3109/00498254.2012.669080. Epub 2012 Apr 18.
8
Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.人肝细胞内在清除率值的实验室间变异性及其与理化性质的趋势。
Pharm Res. 2019 May 31;36(8):113. doi: 10.1007/s11095-019-2645-0.
9
A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.一种使用悬浮于血清中的分离肝细胞预测体内药物代谢清除率的便捷体外筛选方法。
Drug Metab Dispos. 2000 Dec;28(12):1518-23.
10
In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.体外-体内清除推断:高度结合药物的肝代谢清除建模及与现有计算方法的比较评估。
J Pharm Sci. 2012 Feb;101(2):838-51. doi: 10.1002/jps.22792. Epub 2011 Oct 18.

引用本文的文献

1
Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions.利用体外和体内数据的一致性来评估外推假设。
PLoS One. 2019 May 28;14(5):e0217564. doi: 10.1371/journal.pone.0217564. eCollection 2019.